Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation

A. Tyndall (Florence, Italy)

Source: International Congress 2018 – Respiratory medicine meets rheumatology
Session: Respiratory medicine meets rheumatology
Session type: Symposium
Number: 5143

WebcastSlide presentation

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Tyndall (Florence, Italy). Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation. International Congress 2018 – Respiratory medicine meets rheumatology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systemic sclerosis and bilateral lung transplantation: a single centre experience
Source: Eur Respir J 2010; 36: 893-900
Year: 2010



Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017

Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Restrictive chronic lung function decline after haematopoietic stem cell transplantation
Source: Eur Respir J 2016; 47: 336-339
Year: 2016


Fludarabine in paediatric steroid-refractory inflammatory lung injury after stem cell transplantation
Source: Eur Respir J 2013; 41: 479-483
Year: 2013


Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003

Pretransplant lung function tests in patients with malignant hemopathy undergoing stem cell transplantation.
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021


Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016

Undifferentiated connective tissue disease at risk for systemic sclerosis: is heart function already impaired?
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004



Lung transplantation for systemic sclerosis and other connective tissue diseases
Source: International Congress 2017 – Difficult indications for lung transplantation
Year: 2017


Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010

Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015


Late Breaking Abstract - High cumulative dose of allogeneic mesenchymal stem cells in patients with progressive idiopathic pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019


Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006


Early lung function alterations after allogeneic hematopoietic stem cell transplantation
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010

Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant
Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017
Year: 2018



The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2008 - Pathophysiology of acute lung injury
Year: 2008